Found: 14
Select item for more details and to access through your institution.
Identification of RCC Subtype-Specific microRNAs–Meta-Analysis of High-Throughput RCC Tumor microRNA Expression Data.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 548, doi. 10.3390/cancers13030548
- By:
- Publication type:
- Article
Erratum: Structural, topological, and functional characterization of transmembrane proteins TMEM213, 207, 116, 72 and 30B provides a potential link to ccRCC etiology: Am J Cancer Res. 2023; 13(5): 1863-1883.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Interleukin-6 (IL-6) and C-reactive protein (CRP) concentration prior to total nephrectomy are prognostic factors in localized renal cell carcinoma (RCC).
- Published in:
- Reports of Practical Oncology & Radiotherapy, 2013, v. 18, n. 5, p. 304, doi. 10.1016/j.rpor.2013.06.002
- By:
- Publication type:
- Article
Conformal radiotherapy (3D CRT) for non-metastatic androgen-independent prostate cancer: costly and sophisticated but ineffective treatment?
- Published in:
- Reports of Practical Oncology & Radiotherapy, 2008, v. 13, n. 2, p. 78, doi. 10.1016/S1507-1367(10)60086-7
- By:
- Publication type:
- Article
Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2015, v. 19, n. 1, p. 1, doi. 10.5114/wo.2015.50010
- By:
- Publication type:
- Article
The use of luteinizing hormone-releasing hormone analogues is still an indispensable element of therapy in castrate-resistant prostate cancer.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2014, v. 18, n. 2, p. 85, doi. 10.5114/wo.2014.42723
- By:
- Publication type:
- Article
Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1530-4
- By:
- Publication type:
- Article
Potential protective role of Grainyhead-like genes in the development of clear cell renal cell carcinoma.
- Published in:
- Molecular Carcinogenesis, 2017, v. 56, n. 11, p. 2414, doi. 10.1002/mc.22682
- By:
- Publication type:
- Article
Radiotherapy combined with hormonal therapy in prostate cancer: the state of the art.
- Published in:
- Cancer Management & Research, 2010, v. 2, p. 243, doi. 10.2147/CMR.S8912
- By:
- Publication type:
- Article
What is the possible role of PSA doubling time (PSADT ) and PSA velocity (PSAV ) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?
- Published in:
- Central European Journal of Urology, 2011, v. 64, n. 2, p. 67, doi. 10.5173/ceju.2011.02.art3
- By:
- Publication type:
- Article
Leptin receptor isoforms in benign prostatic hyperplasia (BPH). BPH and prostate cancer - no association between plasma concentrations of leptin and prostate specific antigen (PSA).
- Published in:
- Central European Journal of Urology, 2009, v. 62, n. 2, p. 96, doi. 10.5173/ceju.2009.02.art8
- By:
- Publication type:
- Article
Benefit of Whole Pelvic Radiotherapy Combined with Neoadjuvant Androgen Deprivation for the High-Risk Prostate Cancer.
- Published in:
- Journal of Biomedicine & Biotechnology, 2009, p. 1, doi. 10.1155/2009/625394
- By:
- Publication type:
- Article
ZFP91-A Newly Described Gene Potentially Involved in Prostate Pathology.
- Published in:
- Pathology & Oncology Research, 2014, v. 20, n. 2, p. 453, doi. 10.1007/s12253-013-9716-z
- By:
- Publication type:
- Article
Elevated Blood Active Ghrelin and Unaltered Total Ghrelin and Obestatin Concentrations in Prostate Carcinoma.
- Published in:
- Urologia Internationalis, 2009, v. 83, n. 4, p. 471, doi. 10.1159/000251190
- By:
- Publication type:
- Article